Evidence on ergogenic action of glucocorticoids as a doping agent risk

Physician and Sportsmedicine

Volumn 38, Issue 3, 2010, Pages 121-127

  Duclos, Martine ^a,b,c,d  

^a SERVICE DE RHUMATOLOGIE   (France)

^b INRA and University of Auvergne   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d CRNH AUVERGNE   (France)

Author keywords

Adrenal insufficiency; Adverse effects; Doping; Exercise; Glucocorticoids; Performance

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE ACETATE; NITRIC OXIDE; POTASSIUM PUMP; PREDNISOLONE; SODIUM;

ACUTE DRUG ADMINISTRATION; ATHLETIC PERFORMANCE; CARBOHYDRATE METABOLISM; CORTICOTROPIN BLOOD LEVEL; DISEASE ASSOCIATION; DOPING; DRUG ABUSE; DRUG EFFECT; DRUG USE; EVIDENCE BASED MEDICINE; EXERCISE; GLYCOGEN SYNTHESIS; HEALTH HAZARD; HEART RATE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MUSCLE ATROPHY; MUSCLE WEAKNESS; OXYGEN CONSUMPTION; PHYSIOLOGY; PROTEIN INTAKE; REVIEW; RISK;

ANIMALS; ATHLETIC PERFORMANCE; DOPING IN SPORTS; GLUCOCORTICOIDS; HUMANS; SUBSTANCE ABUSE DETECTION;

EID: 78650359552     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2010.10.1817     Document Type: Review

References (42)

1. WADA list of doping classes and methods. World Anti-Doping Agency: 2009. http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP-Prohibited- list/WADA-Prohibited-List-2010-EN.pdf. Accessed September 18, 2010.
2. Duclos M. Hypothalamo-pituitary-adrenal axis adaptation to repeated and prolonged exercise-induced cortisol secretion in endurance training: physiology is the first target. In: Selkirk TB, ed. Focus on Exercise and Health Research. New York, NY: NovaScience Publishers; 2005:131-161.
3. Duclos M, Guinot M, Lebouc Y. Cortisol and GH: odd and controversial ideas. Appl Physiol Nutr Metab. 2007;32(5):895-903.
4. Sapolsky RM, Romero M, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55-89.
5. Duclos M, Gouarne C, Bonnemaison D. Acute and chronic effects of exercise on tissue sensitivity to glucocorticoids. J Appl Physiol. 2003;94(3): 869-875.
6. Piazza PV, Rougé-Pont F, Deroche V, Maccari S, Simon H, Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci U S A. 1996;93(16): 8716-8720. (Pubitemid 26269626)
7. Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocr Rev. 2003;24(4):523-538.
8. Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet. 2005;365(9461):801-803.
9. Marquet P, Lac G, Chassain AP, Habrioux G, Galen FX. Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones. J Appl Physiol. 1999;87(1):175-182.
10. Petrides JS, Gold PW, Mueller GP, et al. Marked differences in functioning of the hypothalamic-pituitary-adrenal axis between groups of men. J Appl Physiol. 1997;82(6):1979-1988.
11. Arlettaz A, Collomp K, Portier H, et al. Effects of acute prednisolone administration on exercise endurance and metabolism. Br J Sports Med. 2008;42(4):250-254. (Pubitemid 351547685)
12. Arlettaz A, Collomp K, Portier H, Lecoq AM, Pelle A, de Ceaurriz J. Effects of acute prednisolone intake during intense submaximal exercise. Int J Sports Med. 2006;27(9):673-679.
13. Soetens E, De Meirleir K, Hueting JE. No influence of ACTH on maximal performance. Psychopharmacol (Berl). 1995;118(3):260-266.
14. Baume N, Steel G, Edwards T, Thorstensen E, Miller BF. No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen) in cyclists. Eur J Appl Physiol. 2008;104(4):589-600.
15. Kuipers H, Van't Hullenaar GA, Pluim BM, et al. Four weeks' corticosteroid inhalation does not augment maximal power output in endurance athletes. Br J Sports Med. 2008;42(11):568-571.
16. United Nations Educational, Scientific and Cultural Organization; International Convention on the Fight Against Doping: 2005. http://portal. unesco.org/en/ev.php-url-id=31037&url-do=do-topic&rul-section=201.html. Accessed October 19, 2010.
17. Brotman DJ, Girod JP, Garcia MJ, et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab. 2005;90(6):3202-3208.
18. Arlettaz A, Portier H, Lecoq AM, Rieth N, De Ceaurriz J, Collomp K. Effects of short-term prednisolone intake during submaximal exercise. Med Sci Sports Exerc. 2007;39(9):1672-1678. (Pubitemid 47360993)
19. Collomp K, Arlettaz A, Portier H, et al. Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br J Sports Med. 2008;42(12):983-988.
20. Le Panse B, Thomasson R, Jollin L, et al. Short-term glucocorticoid intake improves exercise endurance in healthy recreation ally trained women. Eur J Appl Physiol. 2009;107(4):437-443.
21. + homeostasis during exercise in humans. J Physiol. 2008;586(5):1447-1459.
22. Duclos M, Gatti C, Bessière B, Mormède P. Tonic and phasic effects of corticosterone on food restriction-induced hyperactivity in rats. Psychoneuroendocrinology. 2008;34(3):436-445.
23. Rougé-Pont F, Deroche V, Le Moal M, Piazza PV. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci. 1998;10(12):3903-3907.
24. 2 uptake, and endurance. J Appl Physiol. 1988;64(3):1098-1106.
25. Capaccio JA, Galassi TM, Hickson RC. Unaltered aerobic power and endurance following glucocorticoid-induced muscle atrophy. Med Sci Sports Exerc. 1985;17(3):380-384.
26. Ruzzin J, Jensen J. Contraction activates glucose uptake and glycogen synthase normally in muscles from dexamethasone-treated rats. Am J Physiol Endocrinol Metab. 2005;289(2):E241-E250.
27. Short KR, Bigelow ML, Nair KS. Short-term prednisone use antagonizes insulins anabolic effect on muscle protein and glucose metabolism in young healthy people. Am J Physiol Endocrinol Metab. 2009;297(6):E1260-E1268.
28. Horber FF, Scheidegger JR, Grünig BE, Frey FJ. Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab. 1985;61(1):83-88.
29. LaPier TK. Glucocorticoid-induced muscle atrophy. The role of exercise in treatment and prevention. J Cardiopulm Rehabil. 1997;17(2):1776-1784.
30. Barel M, Perez OA, Giozzet VA, Rafacho A, Bosqueiro JR, do Amaral SL. Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment. Eur J Appl Physiol. 2010;108(5):999-1007.
31. Short KR, Nygren J, Bigelow ML, Nair KS. Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. J Clin Endocrinol Metab. 2004;89(12):6198-6207.
32. Iuchi T, Akaike M, Mitsui T, et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res. 2003;92(1):81-87.
33. Duclos M, Gouarne C, Martin C, Rocher C, Mormède P, Letellier T. Effects of corticosterone on muscle mitochondria identifying different sensitivity to glucocorticoids in Lewis and Fischer rats. Am J Physiol Endocrinol Metab. 2004;286(2):E159-E167.
34. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counter regulation after antecedent hypoglycemia in normal humans. J Clin Invest. 1996;98(3):680-691.
35. McGregor VP, Banarer S, Cryer PE. Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia. Am J Physiol Endocrinol Metab. 2002;282(4):E770-E777.
36. Guinot M, Duclos M, Idres N, Souberbielle JC, Megret A, Le Bouc Y. Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists. Eur J Appl Physiol. 2007;99(3):205-216.
37. Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000;355(9203):542-545.
38. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab. 1995;80(4):1243-1246.
39. Kannisto S, Korppi M, Arikoski P, Remes K, Vontilainen R. Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy. Pediatr Res. 2002;52(2):258-262.
40. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87(6):457-461.
41. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727-734.
42. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335(16): 1206-1212.